Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago’s Pritzker School of Molecular Engineering (PME) have developed
The source of this post might be. But the study is solid as far as I can see. It was published in Nature Biomedical Engineering last week.
https://www.nature.com/articles/s41551-023-01086-2
As phase I clinical trials are underway, we’ll see how far this can get. But sure, don’t expect too much, then you won’t be disappointed. Let’s hope it can really help people.
It seems like a decently written article… certainly more readable than the abstract of the scientific article.